Loading data
RNTXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Research and development expense | 11.03 m USD | 14.25 m USD | 3.99 m USD | 17.97 m USD | 17.01 m USD |
| Operating profit | -50.63 m USD | -65.11 m USD | -16.28 m USD | -27.65 m USD | -26.61 m USD |
| Income tax expense | -712 k USD | -1.54 m USD | 0 USD | — | — |
| Net income (reported basis) | -49.9 m USD | -62.9 m USD | -15.7 m USD | -27.3 m USD | -26.16 m USD |
| Basic earnings per share | -1.96 USD/share | -3.51 USD/share | -3.42 USD/share | -6.02 USD/share | -5.89 USD/share |
| Diluted earnings per share | -1.96 USD/share | -3.51 USD/share | -3.42 USD/share | -6.02 USD/share | -5.89 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.